Semzuvolimab

Modify Date: 2024-01-27 14:48:47

Semzuvolimab Structure
Semzuvolimab structure
Common Name Semzuvolimab
CAS Number 2409099-32-5 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Semzuvolimab


Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection[1][2].

 Names

Name Semzuvolimab

 Semzuvolimab Biological Activity

Description Semzuvolimab is a murine IgG1κ antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Murine CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection[1][2].
Related Catalog
References

[1]. Wang Changyi, et al. Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients. World Intellectual Property Organization, WO2018035001 A1. 2018-02-22.

[2]. Semzuvolimab. IMGT/mAb-DB.

 Chemical & Physical Properties

No Any Chemical & Physical Properties